Drug-Eluting Rubber Bands for Tissue Ligation.

controlled release drug delivery drug release elastomer hemorrhoids pain management rubber

Journal

ACS applied materials & interfaces
ISSN: 1944-8252
Titre abrégé: ACS Appl Mater Interfaces
Pays: United States
ID NLM: 101504991

Informations de publication

Date de publication:
22 Jun 2022
Historique:
pubmed: 8 6 2022
medline: 24 6 2022
entrez: 7 6 2022
Statut: ppublish

Résumé

Rubber band ligation is a commonly used method for the removal of tissue abnormalities. Most often, rubber band ligation is performed to remove internal hemorrhoids unresponsive to first line treatments to avoid surgery. While the procedure is considered safe, patients experience mild to significant pain and discomfort until the tissue sloughs off. As patients often require multiple bandings and sessions, reducing these side effects can have a considerable effect on patient adherence and quality of life. To reduce pain and discomfort, we developed drug-eluting rubber bands for ligation procedures. We investigated the potential for a band to elute anesthetics and drug combinations to durably manage pain for a period of up to 5 days while exhibiting similar mechanical properties to conventional rubber bands. We show that the rubber bands retain their mechanical properties despite significant drug loading. Lidocaine, released from the bands, successfully altered the calcium dynamics of cardiomyocytes

Identifiants

pubmed: 35670525
doi: 10.1021/acsami.2c06175
pmc: PMC10015968
mid: NIHMS1864918
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

27675-27685

Subventions

Organisme : NIAMS NIH HHS
ID : F31 AR079215
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Références

Braz J Med Biol Res. 2003 Oct;36(10):1433-9
pubmed: 14502378
J Physiol. 2002 Nov 15;545(1):81-92
pubmed: 12433951
Antiviral Res. 2010 Dec;88 Suppl 1:S30-9
pubmed: 21109066
Circulation. 1963 Oct;28:486-91
pubmed: 14068756
Int J Pharm. 2004 Mar 19;272(1-2):151-60
pubmed: 15019078
Carcinogenesis. 2015 Mar;36(3):400-11
pubmed: 25653236
Dis Colon Rectum. 1993 Mar;36(3):287-90
pubmed: 8449135
Surgery. 2005 May;137(5):571-3
pubmed: 15855932
PLoS One. 2014 Feb 28;9(2):e90266
pubmed: 24587307
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2979-84
pubmed: 9501201
Swiss Med Wkly. 2015 Dec 23;145:w14227
pubmed: 26700795
Cochrane Database Syst Rev. 2017 Nov 09;11:CD011770
pubmed: 29121400
World J Gastrointest Endosc. 2012 Jul 16;4(7):312-22
pubmed: 22816012
Int J Biomater. 2014;2014:157952
pubmed: 25587278
Exp Cell Res. 2012 Apr 15;318(7):828-34
pubmed: 22342953
Schmerz. 2005 Jun;19(3):214-9
pubmed: 15004747
Dis Colon Rectum. 1999 Mar;42(3):363-6
pubmed: 10223757
J Occup Health. 2016 May 25;58(2):138-44
pubmed: 27010091
Sci Rep. 2015 Sep 21;5:14167
pubmed: 26387482
Am J Obstet Gynecol. 1978 Mar 1;130(5):567-8
pubmed: 629314
World J Gastrointest Surg. 2016 Sep 27;8(9):614-620
pubmed: 27721924
Expert Rev Clin Immunol. 2011 Jul;7(4):419-28
pubmed: 21790284
Nat Mater. 2018 Apr;17(4):361-368
pubmed: 29403054
Br J Clin Pharmacol. 2015 Sep;80(3):372-80
pubmed: 25808113
J Biomater Sci Polym Ed. 2020 Apr;31(5):642-657
pubmed: 31860378
Nat Rev Immunol. 2010 Dec;10(12):826-37
pubmed: 21088683
Surg Laparosc Endosc Percutan Tech. 2010 Dec;20(6):e204-5
pubmed: 21150403
Anesth Prog. 2016 Spring;63(1):17-24
pubmed: 26866407
Animals (Basel). 2020 Dec 10;10(12):
pubmed: 33321859
J Pharm Sci. 2013 Jul;102(7):2221-34
pubmed: 23650152
Eur Rev Med Pharmacol Sci. 2016 Jun;20(12):2742-51
pubmed: 27383331
AAPS PharmSciTech. 2012 Jun;13(2):556-67
pubmed: 22476973
Minerva Gastroenterol Dietol. 2015 Dec;61(4):223-33
pubmed: 26446683

Auteurs

Ron Feiner (R)

Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.

Eleanor Johns (E)

Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
Gerstner Sloan Kettering Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.

Merav Antman-Passig (M)

Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.

Takeshi Irie (T)

Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.

Naxhije Berisha (N)

Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
Ph.D. Program in Chemistry, The Graduate Center of the City University of New York, New York, New York 10016, United States.
Department of Nanotechnology, Advanced Science Research Center (ASRC) at the Graduate Center of the City University of New York, New York, New York 10031, United States.

Hadas Oved (H)

Shmunis School of Biomedicine and Cancer Research, Faculty of Life Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.

Doha Khan (D)

Division of Biomaterials, Department of Molecular Pathobiology, NYU College of Dentistry, New York, New York 10010, United States.

Lukasz Witek (L)

Division of Biomaterials, Department of Molecular Pathobiology, NYU College of Dentistry, New York, New York 10010, United States.
Department of Biomedical Engineering, NYU Tandon School of Engineering, Brooklyn, New York 11201, United States.

Richard M White (RM)

Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
Weill Cornell Medical College, New York, New York 10065, United States.

Daniel A Heller (DA)

Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, United States.
Weill Cornell Medical College, New York, New York 10065, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH